(Q70027907)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3955900%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

title

Porphyria cutanea tarda. Diagnosis, management, and differentiation from other hepatic porphyrias (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3955900%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference

Grossman ME

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3955900%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

Poh-Fitzpatrick MB

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3955900%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

publication date

1 April 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3955900%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3955900%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3955900%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3955900%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

page(s)

297-309

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3955900%20AND%20SRC:MED&resulttype=core&format=json

The effect of treatment on plasma uroporphyrin levels in cutaneous hepatic porphyria

7 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Cutaneous skin changes probably due to pyridoxine abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Porphyria Cutanea Tarda in Three Generations of a Single Family

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

INDUSTRIALLY ACQUIRED PORPHYRIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Porphyria cutanea tarda-like syndrome in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Observations on porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Haemophilia, hepatitis and porphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Phototoxic blisters from high frusemide dosage

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Contraceptive pill-induced porphyria cutanea tarda presenting with onycholysis of the finger nails

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Subacute cutaneous lupus erythematosus and porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Primary carcinoma of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Oral contraceptives and exacerbation of lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

The pattern of porphyrin isomer accumulation and excretion in symptomatic porphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Porphyria and scleroderma: a clinical and laboratory review of 12 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Differentiation of porphyria cutanea tarda symptomatica from other types of porphyria by measurement of isocoproporphyrin in faeces

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

The primary enzyme defect in hereditary coproporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Porphyria cutanea tarda. A study of the effect of phlebotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Porphyria-like Cutaneous Changes Induced by Tetracycline Hydrochloride Photosensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Iron and hepatic uroporphyrin synthesis. Relation in porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Effect of chloroquine on hepatic uroporphyrin metabolism in patients with porphyria cutanea tarda.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Excretion of δ-aminolevulinic acid in hereditary tyrosinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Advances in the treatment of porphyria cutanea tarda. Effectiveness of slow subcutaneous desferrioxamine infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Letter: Porphyria cutanea tarda in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Bullous Dermatosis of Hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Hereditary coproporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Porphyria cutanea tarda and bullous dermatoses associated with chronic renal failure: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Erythropoietic Protoporphyria: Lipid Peroxidation and Red Cell Membrane Damage Associated with Photohemolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Porphyria cutanea tarda. Diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Porphyria and pseudoporphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Pseudoporphyria due to naproxen

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

[General symptoms of late skin porphyria (porphyria cutanea tarda) as an indication for its treatment.]

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Phlebotomy and iron-overload in porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Antinuclear Antibodies, Rheumatoid Factor and c-Reactive Protein in Serum of Normal Women Using Oral Contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Bullous dermatosis of chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Ciguatera in Puerto Rico and the Virgin Islands.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

The role of iron in the pathogenesis of porphyria cutanea tarda. An in vitro model

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Complement-derived chemotactic activity is generated in human serum containing uroporphyrin after irradiation with 405 nm light

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Generation of chemotactic activity in serum from patients with erythropoietic protoporphyria and porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Porphyria cutanea tarda and sarcoidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

The effect of replenishment of iron stores after phlebotomy therapy in porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Hepatic fluorescence in porphyria cutanea tarda studied in fine needle aspiration biopsy smears

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Iron storage in porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Skin porphyrin assay in porphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Porphyria during chloroquine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Small volume plasmapheresis in the management of porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

1 reference

7 January 2021

Human porphyria cutanea tarda. Isolation and properties of the urinary porphyrins

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Vitamin E and porphyrin metabolism in man

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Ophthalmological safety of chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Pathogenesis and treatment of photocutaneous manifestations of the porphyrias

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

A plasma porphyrin fluorescence marker for variegate porphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Porphyrin-sensitized cutaneous photosensitivity: pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Porphyria cutanea tardia in two patients treated with hemodialysis for chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Rates of plasma porphyrin disappearance in fluorescent vs. red incandescent light exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Porphyria cutanea tarda associated with chronic renal disease and hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

2,3,7,8-Tetrachlorodibenzo-p-dioxin: a potent inducer of -aminolevulinic acid synthetase

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

A health survey of workers in a 2,4-D and 2,4,5-T plan with special attention to chloracne, porphyria cutanea tarda, and psychologic parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Two cases in infantile and familial porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Stimulators and Inhibitors of Hepatic Porphyrin Formation in Human Sera

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

EXPERIMENTAL PORPHYRIA IN RATS INDUCED BY CHLORINATED BENZENES

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Cutaneous Porphyria in Turkey

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

The Molecular Basis of the Action of Chloroquine in Porphyria Cutanea Tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Effect of Ethanol on Liver δ-Aminolaevulinate Synthetase Activity and Urinary Porphyrin Excretion in Symptomatic Porphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Porphyria cutanea tarda in Ethiopia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Phlebotomy therapy in cutaneous porphyria. Effect on iron and trace metals

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Metabolic Alkalinization in Porphyria Cutanea Tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

Carbamazepine-induced non-hereditary acute porphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

PHOTOTOXIC REACTION WITH NALIDIXIC ACID

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2818%2930834-9

7 January 2021

10.1016/S0733-8635(18)30834-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3955900%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference